Mallinckrodt completes $425 million deal
September 26, 2017 at 08:30 AM EDT
Mallinckrodt has closed on its acquisition of specialty pharmaceutical firm InfaCare Pharmaceutical Corp.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.